https://pubmed.ncbi.nlm.nih.gov/37098099/

J Pediatr Gastroenterol Nutr. 2023 Apr 25.
doi: 10.1097/MPG.0000000000003807.Online ahead of print.

The Liver in Hemophagocytic Lymphohistiocytosis- Not an Innocent Bystander

Tamir Diamond 1 2, Aaron D Bennett 1, Edward M Behrens 2 3

Abstract

Hemophagocytic Lymphohistiocytosis (HLH) is a rare multisystemic hyperinflammatory disease commonly associated with hepatic dysfunction. Liver injury is mediated by unchecked antigen presentation, hypercytokinemia, dysregulated cytotoxicity by Natural Killer (NK) and CD8 T cells and disruption of intrinsic hepatic metabolic pathways. Over the past decade there have been significant advances in diagnostics and expansion in therapeutic armamentarium for this disorder allowing for improved morbidity and mortality. This review discusses the clinical manifestations and pathogenesis of HLH hepatitis in both familial and secondary forms. It will review growing evidence that the intrinsic hepatic response to hypercytokinemia in HLH perpetuates disease progression and the novel therapeutic approaches for patients with HLH-hepatitis/liver failure.